Matt, Author at European Medical Journal - Page 96 of 212

A Ketogenic Diet Could Aid Chemotherapy in Treating Cancer

THE KETOGENIC (keto) diet in conjunction with a diabetes drug could augment the effects of chemotherapy, a new study suggests…

Smartphone App Developed to Control Neural Circuits

Conventional drug delivery systems implanted in the brain are bulky, and the rigid metal tubes and optical fibres cause lesions in soft brain tissue…

Protein with Restorative Potential for Hearing Loss Discovered

Hair cells in the inner ear are integral to the detection of sound. Unlike in other mammals and birds, once damaged, human hair cells do not regenerate…

Right Treatment to the Right Patient in Moderate-to-Severe Psoriasis: Discussion on Difference

Dermatologists frequently see psoriasis patients for whom the most troublesome symptoms are not the constant physical discomfort…

ESHRE 2019 – Interview – Prof Michael Grynberg

An interview with Prof Michael Grynberg, Head, Department of Reproductive Medicine & Fertility Preservation, Hôpital Antoine Béclère, at this year’s ESHRE…

An interview with Daniel Carucci, McCann Health

We recently met with Daniel Carucci, Global Medical Director, McCann Health, at the 2019 Cannes Lions Festival of Creativity. Daniel discusses…

Vaccination use Increases Gout Flare Risk

Gout is caused by sodium urate crystals formation in joints, resulting in sudden and severe joint pain. Research had shown that the inflammatory response…

Reduced Coronary Inflammation via Psoriasis Therapy

Associated with heightened systemic inflammation, which elevates the risk of blood vessel disease and diabetes, psoriasis a chronic autoimmune disease…

Optimism and Opportunities with Anti-CGRP Biologics in Migraine: Where Are We Today?

Migraine is a complex neurological disorder with an approximate global prevalence of 15%. It is characterised by a moderate-to-severe unilateral…

Nuclear Factor Erythroid 2-Related Factor 2 as a Gene Modulator of Response to Oxidative Stress in Amyotrophic Lateral Sclerosis

Among the pathogenic mechanisms on motor neuron degeneration leading to amyotrophic lateral sclerosis (ALS), the oxidative stress (OS) theory has been put forward…